is it legal to compound semaglutide FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products Hims is in the crosshairs.

If you cant tolerate the 3 mg dose, treatment should be discontinued as lower doses arent approved for weight management

Pharmacologically mediated marked initial maternal body weight loss and reductions in body weight gain and food consumption coincided with an increase in early pregnancy losses and led to delivery of slightly smaller offspring at 0.075 mg/kg twice weekly (2X human exposure)

of Canada, Obesity Statistics in Canada: Report. Accessed: Nov

This is fundamentally different from how semaglutide and other GLP-1 drugs work

It is metabolically complementary rather than metabolically depleting

What the Current Clinical Evidence Shows Phase 2 trial data published in the NEJM in 2023 show gastrointestinal events including nausea were the most common side effects, were transient and self-limiting in most participants, and were more frequent at higher doses